Literature DB >> 15124941

Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK.

S J Bowman1, G H Ibrahim, G Holmes, J Hamburger, J R Ainsworth.   

Abstract

OBJECTIVE: To establish the prevalence among women of primary Sjögren's syndrome (PSS) in Birmingham, UK.
METHODS: Eight hundred and forty-six female Caucasians from two general practitioner lists were invited to complete a questionnaire that included a screening question on dry eyes and mouth. Individuals who responded positively were evaluated further.
RESULTS: Overall, 65/% of individuals who were sent a questionnaire responded. Two had possible PSS, but were negative for anti-Ro/La antibodies. Our estimates of the prevalence of PSS ranged from < 0.1% up to 0.4%, depending on the assumptions used.
CONCLUSION: Our data support previous studies suggesting a prevalence of PSS in the community of 0.1-0.6% rather than those suggesting a higher figure.

Entities:  

Mesh:

Year:  2004        PMID: 15124941     DOI: 10.1080/03009740310004676

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  50 in total

1.  Crying Without Tears: Dimensions of Crying and Relations With Ocular Dryness and Mental Well-Being in Patients With Sjögren's Syndrome.

Authors:  N van Leeuwen; E R Bossema; R R Vermeer; A A Kruize; H Bootsma; A J J M Vingerhoets; J W J Bijlsma; R Geenen
Journal:  J Clin Psychol Med Settings       Date:  2016-03

2.  Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.

Authors:  E Theander; G Henriksson; O Ljungberg; T Mandl; R Manthorpe; L T H Jacobsson
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

3.  Sjögren's syndrome associated with antiphospholipid syndrome and fetal myocardial echogenicity: case report.

Authors:  Annamaria Giacobbe; Roberta Grasso; Grazia Foti; Maria Lieta Interdonato; Alfredo Mancuso
Journal:  J Prenat Med       Date:  2013-04

4.  Treating Sjögren's Syndrome: Insights for the Clinician.

Authors:  Claudio Vitali; Gianluigi Palombi; Pierluigi Cataleta
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-06       Impact factor: 5.346

5.  Current Aspects of Pathogenesis in Sjögren's Syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-12       Impact factor: 5.346

Review 6.  Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Nat Rev Rheumatol       Date:  2010-08-03       Impact factor: 20.543

7.  Loss of PKCδ results in characteristics of Sjögren's syndrome including salivary gland dysfunction.

Authors:  G P Banninger; S Cha; M S Said; K M Pauley; C J Carter; M Onate; B A Pauley; S M Anderson; M E Reyland
Journal:  Oral Dis       Date:  2011-06-27       Impact factor: 3.511

Review 8.  [Epidemiology of primary Sjörgren's syndrome].

Authors:  G Westhoff; A Zink
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

Review 9.  Genes and Sjögren's syndrome.

Authors:  Beth L Cobb; Christopher J Lessard; John B Harley; Kathy L Moser
Journal:  Rheum Dis Clin North Am       Date:  2008-11       Impact factor: 2.670

10.  Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis.

Authors:  E William St Clair; Marc C Levesque; Eline T Luning Prak; Frederick B Vivino; Chacko J Alappatt; Meagan E Spychala; Josiah Wedgwood; James McNamara; Kathy L Moser Sivils; Lytia Fisher; Philip Cohen
Journal:  Arthritis Rheum       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.